stockrowResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.
- Revenue
- +5.93%
- EPS
- +23.1%
- Free cash flow
- −9.79%
- Total debt
- −38.9%
Quarter to September 2026, against a year earlier
Follow RMD
Alert me
ResMed Inc. (RMD) Operating cash flow
ResMed Inc.'s operating cash flow for fiscal 2026 was $1.8B, unchanged from fiscal 2025. Over the twelve months to 30 September 2026 it was $1.8B. Over the past ten years it has ranged from $351.1M (fiscal 2022) to $1.8B (fiscal 2026) — the current reading is the highest in ten years. Operating cash flow has risen for 4 consecutive fiscal years. ResMed Inc. ranks 5th of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2026 | $1.8B | 3.10% |
| FY2025 | $1.8B | 25.00% |
| FY2024 | $1.4B | 102.11% |
| FY2023 | $693.3M | 97.44% |
| FY2022 | $351.1M | (52.34%) |
| FY2021 | $736.7M | (8.17%) |
| FY2020 | $802.3M | 74.76% |
| FY2019 | $459.1M | (9.10%) |
| FY2018 | $505.0M | 21.97% |
| FY2017 | $414.1M | (24.43%) |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $422.4M | (7.08%) |
| Jun 2026 | $454.6M | (17.96%) |
| Mar 2026 | $554.1M | 63.10% |
| Dec 2025 | $339.7M | (25.71%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BDX Becton, Dickinson and Company compare | $4.0B |
| MDLN Medline Inc. compare | $3.9B |
| ALC Alcon compare | $2.3B |
| RMD ResMed Inc. | $1.8B |
| BAX Baxter International Inc. compare | $1.6B |
| COO The Cooper Companies, Inc. compare | $1.0B |
| ALGN Align Technology, Inc. compare | $749.9M |
| WST West Pharmaceutical Services, Inc. compare | $654.5M |
| SOLV Solventum Corporation compare | $310.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement